Exjade Drug Lawsuit Source

Exjade Side Effects: Gastrointestinal Complications & Skin Rash

Commonly asked questions about the side effects from the use of Exjade:

Exjade Gastrointestinal And Skin Rash Complications

Exjade has been linked to several serious side effects, including renal impairment (including failure), hepatic impairment (including failure) and gastrointestinal hemorrhage.

In 2009, Exjade was ranked No. 2 on the list of “Most Frequent Suspected Drugs in Reported Patient Deaths,” according to the Institute for Safe Medical Practices.

Less serious side effects of Exjade may include:

  • mild nausea, stomach pain, diarrhea, vomiting;
  • dizziness, anxiety, tired feeling;
  • sleep problems (insomnia);
  • mild rash, discolored skin; or
  • headache, cough, sinus pain, runny or stuffy nose.

This controversial drug may rarely cause serious (even fatal) liver disease, as well. If you notice any of the following serious side effects, tell your doctor immediately:

  • persistent nausea/vomiting
  • severe stomach/abdominal pain
  • dark urine
  • yellowing of eyes/skin

Exjade Gastrointestinal Complications And Side Effects

Exjade may cause serious — perhaps fatal — stomach/intestinal problems, including GI ulceration, GI hemorrhage and GI perforation. Bleeding in the stomach or intestines reportedly occurred more often in elderly patients. If you notice any of the following unlikely but serious side effects, stop taking deferasirox and consult your doctor or pharmacist right away

  • severe stomach/abdominal pain
  • black/tarry/bloody stools
  • vomit that looks like coffee grounds
  • severe stomach/abdominal pain
  • Loss of appetite
  • Nausea
  • Diarrhea

Exjade Severe Skin Rash Complications And Side Effects

Severe skin reactions have been reported during Exjade therapy, according to the U.S. Food and Drug Administration. For rashes of mild to moderate severity, Exjade may be continued without dose adjustment, since the rash often resolves spontaneously. Severe skin reactions have been reported during Exjade therapy, including:

  • Steven-Jhonson Syndrom (SJS)
  • Toxic Epidermal Necrolysis (TEN)
  • Erythema Multiforme

In severe cases, please stop taking Exjade and consult your doctor or pharmacist right away.

Our Exjade Lawyers Can Help

Our dangerous drug attorneys can help if you or someone you care about was harmed by Exjade. Patients and their families are currently considering filing lawsuits against the manufacturer of Exjade and could receive compensation for injuries caused by the controversial drug.

You, too, may be entitled to a settlement. We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it all in writing for you. Our lawyers will help you file your lawsuit.

Our No-Fee Promise on Exjade Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Exjade Claim

Our Exjade lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call 1-866-280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Exjade lawsuit claims.

Exjade Gastrointestinal Complications And Sever Skin Rash Lawyer Review

Drug Lawsuit Source Client Review
Review Date
Prescription drug lawyer
Client Rating

View Sources

  1. Exjade Safety – U.S. Food and Drug Administration
  2. Important Safety Information – Exjade Official Website
  3. Fact Sheet: Exjade – Health Canada


  1. Brittenham GM, Griffith PM, Nienhuis AW. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994. 331. 567–73.
  2. Cabantchik ZI, Breuer W, Zanninelli G. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005. 18. 277–87.
  3. Nick H, Wong A, Acklin P. ICL670A. Preclinical profile. Adv Exp Med Biol. 2002. 509. 185–203.